Skip to main content
JAMA Network logoLink to JAMA Network
. 2024 May 13;81(5):556. doi: 10.1001/jamaneurol.2024.1238

Error in Author Name, Figure 3A and C, and Table 1

PMCID: PMC11091754  PMID: 38739181

In the Original Investigation titled “Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial,”1 published online March 25, 2024, author Cristina Lopez Lopez’s surname was written incorrectly, the graph curves in Figure 3A and C were misaligned, and Table 1 was missing a footnote. Cristina Lopez Lopez’s name has been corrected to reflect a surname of Lopez Lopez, the curves in Figure 3A and C have been adjusted to match the correct numbers listed in the article, and the missing footnote was added to Table 1. This article has been corrected online.1

Reference

  • 1.Pozo-Rosich P, Dolezil D, Paemeleire K, et al. Early use of erenumab vs nonspecific oral migraine preventives: the APPRAISE randomized clinical trial. JAMA Neurol. Published online March 25, 2024. doi: 10.1001/jamaneurol.2024.0368 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Neurology are provided here courtesy of American Medical Association

RESOURCES